Literature DB >> 1306122

Interindividual variability of coumarin 7-hydroxylation in healthy volunteers.

A Rautio1, H Kraul, A Kojo, E Salmela, O Pelkonen.   

Abstract

A test designed to estimate the extent and rate of formation of 7-hydroxycoumarin by measuring the urinary excretion of the metabolite in humans after administering 5 mg coumarin was developed. Coumarin was rapidly metabolized after oral administration and more than 95% of the 7OHC formed was excreted in 4 h. The total amount of 7OHC formed was 64 +/- 15% (mean +/- SD, variation 20-100%) of the dose given. The percentage of 7OHC excreted in 2 h, as compared with the 7OHC excretion in 4 h, was found to be a constant and stable individual characteristic for the rate of the formation of 7OHC ('2 h coumarin test'). In 110 volunteers, there was a great interindividual variability in the extent and rate of 7OHC formation. Four individuals had relatively 'slow' coumarin test values (50-60%), but much larger populations would be needed for the demonstration of polymorphism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1306122     DOI: 10.1097/00008571-199210000-00005

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  22 in total

Review 1.  Polymorphisms of CYP2A6 and its practical consequences.

Authors:  H Raunio; A Rautio; H Gullstén; O Pelkonen
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

Review 2.  Assessment of liver metabolic function. Clinical implications.

Authors:  J Brockmöller; I Roots
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

Review 3.  Molecular basis of polymorphic drug metabolism.

Authors:  A K Daly
Journal:  J Mol Med (Berl)       Date:  1995-11       Impact factor: 4.599

Review 4.  Genetic polymorphism of drug metabolizing enzymes: new mutations in CYP2D6 and CYP2A6 genes in Japanese.

Authors:  T Yokoi; T Kamataki
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

5.  Humanized mice with ectopic artificial liver tissues.

Authors:  Alice A Chen; David K Thomas; Luvena L Ong; Robert E Schwartz; Todd R Golub; Sangeeta N Bhatia
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-11       Impact factor: 11.205

6.  Proceedings of the British Pharmacological Society. Clinical Pharmacology Section. 14-16 April 1993. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1993-08       Impact factor: 4.335

Review 7.  Regulation of coumarin 7-hydroxylation in man.

Authors:  O Pelkonen; A Rautio; H Raunio; J Mäenpää; J Hakkola
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

8.  Interindividual variability of coumarin 7-hydroxylation in a Turkish population.

Authors:  M Iscan; H Rostami; M Iscan; T Güray; O Pelkonen; A Rautio
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

9.  CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients.

Authors:  E A Sotaniemi; A Rautio; M Bäckstrom; P Arvela; O Pelkonen
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

10.  CYP2A6 genotypes and coumarin-oxidation phenotypes in a Thai population and their relationship to tobacco smoking.

Authors:  Wiratchanee Mahavorasirikul; Wichittra Tassaneeyakul; Soisagwan Satarug; Ronnatrai Reungweerayut; Chacrin Na-Bangchang; Kesara Na-Bangchang
Journal:  Eur J Clin Pharmacol       Date:  2008-12-13       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.